Clarius Group LLC’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Sell |
978
-69
| -7% | -$17.8K | 0.01% | 401 |
|
|
2025
Q1 | $234K | Sell |
1,047
-24
| -2% | -$5.37K | 0.01% | 424 |
|
|
2024
Q4 | $245K | Buy |
1,071
+4
| +0.4% | +$915 | 0.02% | 370 |
|
|
2024
Q3 | $260K | Sell |
1,067
-52
| -5% | -$12.7K | 0.02% | 353 |
|
|
2024
Q2 | $214K | Sell |
1,119
-101
| -8% | -$19.3K | 0.02% | 401 |
|
|
2024
Q1 | $242K | Sell |
1,220
-205
| -14% | -$40.6K | 0.02% | 406 |
|
|
2023
Q4 | $245K | Buy |
+1,425
| New | +$245K | 0.02% | 407 |
|
|
2023
Q3 | – | Sell |
-1,483
| Closed | -$324K | – | 509 |
|
|
2023
Q2 | $324K | Sell |
1,483
-19
| -1% | -$4.15K | 0.03% | 366 |
|
|
2023
Q1 | $329K | Sell |
1,502
-37
| -2% | -$8.1K | 0.03% | 361 |
|
|
2022
Q4 | $320K | Buy |
1,539
+82
| +6% | +$17.1K | 0.03% | 365 |
|
|
2022
Q3 | $318K | Buy |
1,457
+88
| +6% | +$19.2K | 0.03% | 325 |
|
|
2022
Q2 | $287K | Buy |
1,369
+132
| +11% | +$27.7K | 0.03% | 350 |
|
|
2022
Q1 | $322K | Hold |
1,237
| – | – | 0.03% | 340 |
|
|
2021
Q4 | $322K | Buy |
1,237
+65
| +6% | +$16.9K | 0.03% | 340 |
|
|
2021
Q3 | $309K | Buy |
1,172
+48
| +4% | +$12.7K | 0.03% | 311 |
|
|
2021
Q2 | $277K | Buy |
1,124
+26
| +2% | +$6.41K | 0.02% | 324 |
|
|
2021
Q1 | $213K | Buy |
1,098
+11
| +1% | +$2.13K | 0.02% | 353 |
|
|
2020
Q4 | $231K | Buy |
+1,087
| New | +$231K | 0.02% | 307 |
|